Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas.
| Publicado en: | PharmacoEconomics Vol. 43; no. 7; pp. 793 - 804 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jul2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185943133&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 185943133 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 11707690 C5G jtl: PharmacoEconomics issn: 11707690 maglogo: N pubinfo: dt: Jul2025 vid: 43 iid: 7 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 185943133 184071551 10.1007/s40273-025-01485-0 185943133 ppf: 793 ppct: 11 formats: tig: atl: Defining Biological and Clinical Plausibility: The DICSA Framework for Protocolized Assessment in Survival Extrapolations Across Therapeutic Areas. aug: au: Heeg, Bart Lee, Dawn Adam, Jane Postma, Maarten Ouwens, Mario affil: Cytel, 3012 NJ, Rotterdam, The Netherlands sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|